用N-乙半氨酸功能化的Levofloxacin装载的半孔纳米颗粒的骨质和抗菌反应
Alberto Polo-Montalvo1,2, Natividad Gómez-Cerezo1,3, Mónica Cicuéndez1,2
1Departamento Química en Ciencias Farmacéuticas, Facultad de Farmacia, Universidad Complutense de Madrid, Plaza Ramón y Cajal s/n, 28040 Madrid, Spain.
Pharmaceutics
|April 26, 2025
概括
一个新的纳米系统结合了半孔生物活性玻璃纳米颗粒 (MBGN) 与黄素和N-乙半氨酸 (NAC) 结合起来,通过破坏生物膜并促进骨再生,有效地对抗金黄色葡萄球菌的骨感染.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术 纳米技术
- 整形外科手术 整形外科手术
- 传染性疾病 传染性疾病
背景情况:
- 骨感染是常见的骨科手术并发症,通常是由金黄色葡萄球菌引起的.
- 细菌生物膜使传统的抗生素治疗对骨感染无效.
- 目前治疗骨感染的方法需要新的策略来克服抗生素耐药性并促进组织修复.
研究的目的:
- 开发和评估用于治疗骨感染的纳米系统.
- 拟议的系统使用带有叶黄素和功能化N-乙半氨酸 (NAC) 装载的半孔生物活性玻璃纳米粒子 (MBGN).
- 评估纳米系统对生物膜的抗菌活性及其对骨再生的潜力.
主要方法:
- 合成具有特定SiO2-CaO组成的半孔生物活性玻璃纳米粒子 (MBGN).
- 在MBGN上加载勒沃素和与N-乙半氨酸 (NAC) 的功能化,生成MBGN-L-NAC.
- 对成熟的黄金葡萄球菌生物膜的抗微生物活性,体外生物活性,与前骨质细胞的生物相容性和骨质性潜力的评估.
主要成果:
- 合成的MBGN表现出高表面积和中等度,使其能够有效地负载利沃素 (高达23.1% w/w).
- N-乙半氨酸 (NAC) 成功结合,保留其功能性醇组,并通过破坏金黄色葡萄球菌生物膜来增强抗菌活性.
- 该MBGN-L-NAC纳米系统表现出生物相容性,促进了骨质前分化,增强了矿化,并在体外刺激了骨质生成反应.
结论:
- MBGN-L-NAC纳米系统在抗骨感染方面表现出卓越的抗菌疗效,这归因于NAC的生物膜破坏性.
- NAC功能化增强了MBGNs的骨诱导能力,促进了围植入骨再生.
- 这种纳米系统为传统治疗提供了一个有希望的替代方案,用于管理具有挑战性的骨感染.
相关概念视频
01:27Combined Effects of Drugs: Synergism
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
01:28Antimicrobial Effectiveness
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:28Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...